1600O Efficacy and safety of IMA203, a PRAME-directed T-cell receptor (TCR) T-cell therapy, in patients with previously treated advanced or metastatic uveal melanoma from a phase I trial

作者：Sapna P. Patel, Apostolia M. Tsimberidou, Jason J. Luke, Winfried Alsdorf, Antonia Busse, Susanna DeVane, Silvana Hengler, Norbert Hilf, M. Alper Kursunel, Andrea Mayer-Mokler, Dmitry Pankov, Cedrik M. Britten, Martin Wermke, Leonel F. Hernandez‐Aya · 发表于：Annals of Oncology · 年份：2025 · DOI：10.1016/j.annonc.2025.08.2228 · 被引用次数：7 · 研究领域：Ocular Oncology and Treatments、CAR-T cell therapy research、Immunotherapy and Immune Responses